SIVEM PHARMACEUTICALS — Valacyclovir Importer Profile
Pharmaceutical Importer · #5 buyer for Valacyclovir · $1.7M import value · 34 shipments · UNITED STATES · DGFT Verified
SIVEM PHARMACEUTICALS is the #5 importer of Valacyclovir from India with $1.7M in import value and 34 verified shipments. SIVEM PHARMACEUTICALS holds a 1.7% market share in Valacyclovir imports based in UNITED STATES. The company sources from 1 verified supplier across 2 formulations shipped to 1 country. Overall, SIVEM PHARMACEUTICALS imports 4 pharmaceutical products worth $5.0M across 3 therapeutic categories.
SIVEM PHARMACEUTICALS — Valacyclovir Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Valacyclovir to SIVEM PHARMACEUTICALS?
Verified from 34 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| AUROBINDO PHARMA LIMITED | $1.7M | 34 | 100.0% |
SIVEM PHARMACEUTICALS sources Valacyclovir from 1 verified Indian supplier based on 34 customs records. The primary supplier is AUROBINDO PHARMA LIMITED accounting for 100.0% of imports.
How Does SIVEM PHARMACEUTICALS Compare to Nearest Valacyclovir Importers?
Buyers ranked immediately above and below #5 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 3 | XXMBEXXPHAXXACEXXICAXX IXX | UNITED STATES | $2.5M | 49 | $50.0K |
| 5 | SIVEM PHARMACEUTICALS ★ | UNITED STATES | $1.6M | 31 | $50.0K |
| 8 | JAMP PHARMA CORPORATION | CANADA | $1.3M | 37 | $35.6K |
| 1 | MYLAN PHARMACEUTICALS INC, | UNITED STATES | $1.1M | 23 | $50.0K |
SIVEM PHARMACEUTICALS ranks #5 among 197 Valacyclovir importers from India. Average shipment value of $50.0K compared to the market average of $58.3K. The closest competitors by value are XXMBEXXPHAXXACEXXICAXX IXX and JAMP PHARMA CORPORATION.
Where Does SIVEM PHARMACEUTICALS Import Valacyclovir To?
Destination countries from 34 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED STATES | $1.7M | 34 | 100.0% |
SIVEM PHARMACEUTICALS imports Valacyclovir to 1 country. The primary destination is UNITED STATES receiving 100.0% of shipments worth $1.7M.
What Valacyclovir Formulations Does SIVEM PHARMACEUTICALS Import?
| Formulation | Value | Shipments |
|---|---|---|
| VALACICLOVIR TABLETS 500MG (VALACYCLOVIR | $1.6M | 31 |
| VALACICLOVIR TABLETS 500MG ValacyclovirTablets 500 mg 100'S | $150.0K | 3 |
SIVEM PHARMACEUTICALS imports 2 distinct Valacyclovir formulations from India. The top formulation is VALACICLOVIR TABLETS 500MG (VALACYCLOVIR with 31 shipments worth $1.6M.
Regulatory Requirements: Importing Valacyclovir into United States
What SIVEM PHARMACEUTICALS and other importers must comply with to import Valacyclovir from India
Regulatory Authority
U.S. Food and Drug Administration (FDA)
Approval Process for Generic Valacyclovir
Abbreviated New Drug Application (ANDA) for generic drugs, requiring bioequivalence studies and compliance with 21 CFR. Indian manufacturing sites must pass FDA pre-approval inspection.
Typical timeline: 10–18 months for ANDA approval
GMP Requirements
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA prior to approval
Import Licence & Documentation
Drug Listing with FDA; Import Alert screening; Customs entry via FDA PREDICT system
Labeling & Packaging
US-specific labeling per 21 CFR 201 including NDC number, lot, expiry, dosage in English
Note: Subject to FDA Import Alerts and Automatic Detention if facility has open Form 483 observations.
Regulatory information is provided for general reference based on publicly available FDA guidelines for pharmaceutical imports. Requirements may vary by specific drug formulation, dosage form, and therapeutic classification. Importers should consult directly with FDA or qualified regulatory affairs professionals for case-specific guidance.
Who Are the Top Buyers of Valacyclovir from India and How Much Does SIVEM PHARMACEUTICALS Import?
India exported $11.5M worth of Valacyclovir through 2,537 shipments from 113 suppliers to 70 countries, serving 197 buyers globally. SIVEM PHARMACEUTICALS imports $1.7M of this total, accounting for 1.7% of India's Valacyclovir exports with 34 shipments from UNITED STATES. This is verified from 34 customs shipment records covering 2 distinct formulations.
What Is the Average Order Value for SIVEM PHARMACEUTICALS's Valacyclovir Imports?
SIVEM PHARMACEUTICALS's average Valacyclovir order value is $50.0K per consignment, based on 34 shipments totaling $1.7M. SIVEM PHARMACEUTICALS is based in UNITED STATES and ranks #5 among all Valacyclovir importers from India by value. The company sources from 1 verified supplier in India.
Who Supplies Valacyclovir to SIVEM PHARMACEUTICALS?
SIVEM PHARMACEUTICALS sources Valacyclovir from 1 verified Indian supplier: AUROBINDO PHARMA LIMITED ($1.7M, 100.0%). This is based on 34 customs records.
How Does SIVEM PHARMACEUTICALS Compare to Other Valacyclovir Importers?
SIVEM PHARMACEUTICALS ranks #5 among 197 Valacyclovir importers from India with a 1.7% market share. The top 3 importers are XXMBEXXPHAXXACEXXICAXX IXX ($2.5M), SIVEM PHARMACEUTICALS ($1.6M), JAMP PHARMA CORPORATION ($1.3M). SIVEM PHARMACEUTICALS processed 34 shipments from UNITED STATES.
What Other Antivirals Products Does SIVEM PHARMACEUTICALS Import?
SIVEM PHARMACEUTICALS also imports these antivirals products. Each links to the detailed product page.
About SIVEM PHARMACEUTICALS
SIVEM PHARMACEUTICALS imports 4 products worth $5.0M. Beyond Valacyclovir, top products include Acyclovir, Cephalexin, Simvastatin. View the complete SIVEM PHARMACEUTICALS profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Valacyclovir — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Valacyclovir shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: SIVEM PHARMACEUTICALS matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as SIVEM PHARMACEUTICALS's capped import value divided by total capped export value for Valacyclovir across all Indian exporters.
- 5.Verified Records: This page is backed by 34 individual customs records matching SIVEM PHARMACEUTICALS importing Valacyclovir, covering 2 formulations from 1 verified supplier.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 70+ countries, 197+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Valacyclovir Import Data for SIVEM PHARMACEUTICALS
Access order-level details, pricing data, supplier connections, and competitive analysis for SIVEM PHARMACEUTICALS's Valacyclovir imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
SIVEM PHARMACEUTICALS
Full Company Profile →
4 products · $5.0M total trade · 3 categories
SIVEM PHARMACEUTICALS × Valacyclovir
Verified from customs records
Company Overview
Top Products by SIVEM PHARMACEUTICALS
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for SIVEM PHARMACEUTICALS.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Valacyclovir. For current order-level data, contact TransData Nexus.